Market Moves

21 articles

Market Moves

Former Harvard chemistry chair Charles Lieber leads state-funded Shenzhen BCI lab i-BRAIN

Reuters reported on April 30 that Charles Lieber, the former chair of Harvard's chemistry department convicted in December 2021 under the US China Initiative, has been appointed director of i-BRAIN, a newly established BCI institute at the Shenzhen Medical Academy of Research and Translation. The lab gives Lieber access to dedicated nanofabrication, advanced lithography, and primate research facilities at a scale unavailable to him at Harvard. The appointment lands the same week as Axoft's $55M Asian-led Series A — the capital and talent legs of the same bilateral BCI flow.

Apr 30

Market Moves

Axoft draws C.P. Group lead in $55M Series A as US BCI company runs first acute implant in Shanghai

Cambridge, Massachusetts implantable BCI company Axoft closed a $55M oversubscribed Series A on April 29, led by Thai conglomerate Charoen Pokphand's strategic arm C.P. Group Innovation with Chinese co-investors Hillhouse and Gaorong, alongside US participants Alumni Ventures and Stanford. The same announcement disclosed Axoft's first acute intraoperative test of its Fleuron polymer probe in a Shanghai patient — the first publicly confirmed clinical use of a US BCI material in China, with more Chinese trials planned this year.

Apr 29

Market Moves

Neurable launches OEM licensing programme, opening its EEG-decoder stack to consumer hardware makers

Neurable announced on April 28 that it has formally opened its consumer-EEG technology to OEM licensing, allowing third-party hardware makers to integrate the company's brain-signal-processing stack into their own products. Named integration partners include HP Inc.'s HyperX, MeSpace, iMotions, and the United States Air Force Research Laboratory. The shift recasts Neurable from a hardware company building its own consumer products into a platform layer for the broader consumer-electronics stack.

Apr 28

Market Moves

China issues guided pricing for invasive BCI procedures as provinces begin reimbursement roll-out

China's National Healthcare Security Administration has set government-guided prices of 6,000–6,600 yuan per invasive brain-computer interface implantation procedure, with Sichuan, Hubei and Zhejiang now attaching fee schedules at the provincial level — moving the country further ahead of the United States on the reimbursement layer that will decide whether BCIs scale as routine medicine.

Apr 23

Market Moves

ONWARD Medical Raises €40.6m to Scale ARC Therapy Rollout and Fund Implantable Pipeline

The Eindhoven-listed neurotech priced a private placement at €3.00 per share, led by EQT Life Sciences, to expand ARC-EX commercial operations and advance ARC-IM through regulatory work. Cash runway extends into Q1 2028.

Apr 20

Market Moves

Sabi emerges from stealth with a thought-to-text beanie and Khosla backing

California startup Sabi has exited stealth with a non-invasive EEG beanie packing up to 100,000 miniature sensors, a brain foundation model trained on 100,000 hours of neural data, and a plan to ship a consumer thought-to-text device by the end of 2026. Khosla Ventures leads.

Apr 16

Market Moves

China's First BCI Unicorn Pivots Prosthetics Expertise Into Humanoid Robot Hands

BrainCo's new Revo 3 dexterous hand applies neural decoding and tactile sensing from prosthetic limbs to humanoid robotics, backed by a US$286 million funding round.

Apr 13

Market Moves

Neural Dust Co-Inventor Headlines Bioelectronic Medicine Forum as Neurotech Investment Accelerates

Michel Maharbiz of iota Biosciences will keynote the ninth annual Bioelectronic Medicine Forum in New York on April 14, with panels on reimbursement and venture capital following a record Q1 for BCI funding.

Apr 11

Market Moves

Synchron's Neural Data Ambitions Earn Fast Company Recognition as BCI Dataset Grows

Synchron ranked eighth on Fast Company's 2026 most innovative data science companies list, reflecting a strategic pivot from hardware maker to neural data platform.

Apr 6

Market Moves

Neuronoff's Needle-Delivered Electrode Works With Standard Pulse Generators in Chronic Animal Study

Cleveland-based Neuronoff showed its Injectrode platform can connect to off-the-shelf implantable pulse generators, opening neuromodulation targets beyond the spine.

Apr 5

Market Moves

BCI Sector Closes Record First Quarter With Over $960 Million Raised

At least nine significant funding rounds in Q1 2026 brought total BCI investment past $960 million, with capital spreading across invasive, endovascular, ultrasound, and neurostimulation modalities.

Mar 31

Market Moves

Merge Labs' $252M Bet on Ultrasound BCI Faces Scientific Scrutiny

Sam Altman's brain-computer interface startup raised the second-largest BCI round in history. The scientific community is asking whether the physics adds up.

Mar 28

Market Moves

Octane's Neuro Tech Forum Draws J&J, Medtronic, and Blackrock Neurotech to Newport Beach

The second annual forum brought together device makers, investors, and six early-stage startups for two days of panels on BCI, neuromodulation, and digital health.

Mar 28

Market Moves

Cambridge Innovation Institute Acquires Neurotech Reports After 25 Years of Independent Publishing

CII absorbs the neurotechnology sector's longest-running trade publication into its venture and innovation division, with founder James Cavuoto and team staying on.

Mar 24

Market Moves

Cleveland Startup Sells $350 Brain Stimulation Headset Without FDA Clearance While Clinical Trials Continue

U: The Mind Company began taking orders for a consumer neuromodulation device on March 18, marketing bold clinical claims that have not appeared in peer-reviewed literature. An FDA submission is planned for 2027.

Mar 23

Market Moves

Alibaba Leads $72 Million Round in StairMed as Chinese Tech Giants Enter BCI

The invasive-BCI startup has now raised over $160 million in a year, with Alibaba and Tencent both on the cap table and multicenter clinical trials planned for later this year.

Mar 13

Market Moves

Gestala Raises $21 Million for Ultrasound BCI in Record Chinese Early-Stage Round

The two-month-old startup founded by Shanda billionaire Tianqiao Chen and former NeuroXess founder Phoenix Peng secures the largest early-stage BCI funding in China, betting that focused ultrasound can reach deeper brain circuits than any implant.

Mar 12

Market Moves

Cognito Therapeutics Raises $105M to Bring Alzheimer's Brain Stimulation to Market

The neuromodulation startup closed an oversubscribed Series C led by Morningside Ventures, pushing total funding to $233M as its pivotal Alzheimer's trial nears readout.

Mar 7

Market Moves

Salma Health Raises $80M to Build the Operating System for Brain Care

Backed by Mubadala and ARCH Venture Partners, the startup is merging AI diagnostics with FDA-cleared neuromodulation to consolidate fragmented psychiatric and neurological care.

Mar 7

Market Moves

Science Corp Raises $230 Million to Commercialise PRIMA Retinal Implant

Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.

Mar 6

Market Moves

Gobi Partners Backs Cortical Labs as Biological Computing Hub Expands in Malaysia

Malaysia-based Gobi Partners has invested in Cortical Labs through its Dana Impak Ventures fund, joining Horizon Ventures and Synchron founder Tom Oxley in backing the biological computing startup.

Mar 5

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.